Inhibitors of L1 and ADAM10 for the treatment of carcinomas
Described is a pharmaceutical composition comprising a compound(s) interfering with the biological activity of L1 and/or ADAM10 or their expression. Also described is the use of said compound(s) for the prevention/treatment of carcinomas like ovarian and endometrial carcinoma. Finally, the diagnosis...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Altevogt, Peter Kelm, Daniela Fogel, Mina |
| description | Described is a pharmaceutical composition comprising a compound(s) interfering with the biological activity of L1 and/or ADAM10 or their expression. Also described is the use of said compound(s) for the prevention/treatment of carcinomas like ovarian and endometrial carcinoma. Finally, the diagnosis of highly malignant forms of carcinomas which is based on the determination of the activity/expression of L1 and/or ADAM10 is described. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08003599</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08003599</sourcerecordid><originalsourceid>FETCH-uspatents_grants_080035993</originalsourceid><addsrcrecordid>eNrjZLD2zMvITMosyS8qVshPU_AxVEjMS1FwdHH0NTRQSMsvUijJSFUoKUpNLMlNzSsBKUlOLErOzMvPTSzmYWBNS8wpTuWF0twMCm6uIc4euqXFBYklQOXF8elFiSDKwMLAwNjU0tKYCCUAoboumQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Inhibitors of L1 and ADAM10 for the treatment of carcinomas</title><source>USPTO Issued Patents</source><creator>Altevogt, Peter ; Kelm, Daniela ; Fogel, Mina</creator><creatorcontrib>Altevogt, Peter ; Kelm, Daniela ; Fogel, Mina ; Deutsches Krebsforschungszentrum</creatorcontrib><description>Described is a pharmaceutical composition comprising a compound(s) interfering with the biological activity of L1 and/or ADAM10 or their expression. Also described is the use of said compound(s) for the prevention/treatment of carcinomas like ovarian and endometrial carcinoma. Finally, the diagnosis of highly malignant forms of carcinomas which is based on the determination of the activity/expression of L1 and/or ADAM10 is described.</description><language>eng</language><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8003599$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8003599$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Altevogt, Peter</creatorcontrib><creatorcontrib>Kelm, Daniela</creatorcontrib><creatorcontrib>Fogel, Mina</creatorcontrib><creatorcontrib>Deutsches Krebsforschungszentrum</creatorcontrib><title>Inhibitors of L1 and ADAM10 for the treatment of carcinomas</title><description>Described is a pharmaceutical composition comprising a compound(s) interfering with the biological activity of L1 and/or ADAM10 or their expression. Also described is the use of said compound(s) for the prevention/treatment of carcinomas like ovarian and endometrial carcinoma. Finally, the diagnosis of highly malignant forms of carcinomas which is based on the determination of the activity/expression of L1 and/or ADAM10 is described.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZLD2zMvITMosyS8qVshPU_AxVEjMS1FwdHH0NTRQSMsvUijJSFUoKUpNLMlNzSsBKUlOLErOzMvPTSzmYWBNS8wpTuWF0twMCm6uIc4euqXFBYklQOXF8elFiSDKwMLAwNjU0tKYCCUAoboumQ</recordid><startdate>20110823</startdate><enddate>20110823</enddate><creator>Altevogt, Peter</creator><creator>Kelm, Daniela</creator><creator>Fogel, Mina</creator><scope>EFH</scope></search><sort><creationdate>20110823</creationdate><title>Inhibitors of L1 and ADAM10 for the treatment of carcinomas</title><author>Altevogt, Peter ; Kelm, Daniela ; Fogel, Mina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_080035993</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Altevogt, Peter</creatorcontrib><creatorcontrib>Kelm, Daniela</creatorcontrib><creatorcontrib>Fogel, Mina</creatorcontrib><creatorcontrib>Deutsches Krebsforschungszentrum</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Altevogt, Peter</au><au>Kelm, Daniela</au><au>Fogel, Mina</au><aucorp>Deutsches Krebsforschungszentrum</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Inhibitors of L1 and ADAM10 for the treatment of carcinomas</title><date>2011-08-23</date><risdate>2011</risdate><abstract>Described is a pharmaceutical composition comprising a compound(s) interfering with the biological activity of L1 and/or ADAM10 or their expression. Also described is the use of said compound(s) for the prevention/treatment of carcinomas like ovarian and endometrial carcinoma. Finally, the diagnosis of highly malignant forms of carcinomas which is based on the determination of the activity/expression of L1 and/or ADAM10 is described.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_08003599 |
| source | USPTO Issued Patents |
| title | Inhibitors of L1 and ADAM10 for the treatment of carcinomas |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T03%3A38%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Altevogt,%20Peter&rft.aucorp=Deutsches%20Krebsforschungszentrum&rft.date=2011-08-23&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08003599%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |